secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2022-05-16T23:59:59+00:00
Accession:  0001640334-22-001024
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences enters $20M common stock purchase agreement with Lincoln Park Capital
--------------------------------------------------------------------------------

- Company may sell up to $20M of common stock over 36 months at discounts of 3-5% to market price.
- Lincoln Park received 292,968 commitment shares as consideration for entering the agreement.
- Proceeds from any sales will be used for working capital and general corporate purposes; company has no obligation to sell.
- Regular purchases limited to 200,000 shares per day, increased if stock price exceeds $0.50 or $0.75, max $1M per purchase.
- Accelerated purchases allowed at 95% of closing or VWAP, with additional accelerated purchases possible on same day.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033422001024/0001640334-22-001024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033422001024/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-22-001024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer